Quarterly report pursuant to Section 13 or 15(d)

Balance Sheet Components (Details) - Schedule of accrued liabilities

v3.22.2.2
Balance Sheet Components (Details) - Schedule of accrued liabilities - USD ($)
$ in Thousands
Jun. 30, 2022
Dec. 31, 2021
Schedule of accrued liabilities [Abstract]    
Accrued labor costs $ 1,357 $ 691
Accrued drug development costs 439 369
Other 131 152
Total $ 1,927 $ 1,212